AXSM· Axsome Therapeutics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 5 | $12M |
Quarterly ownership history
Last 6 quarters
AXSM Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$11.2B
Enterprise value$11.1B
EV / EBITDA (TTM)-66.38
P/E ratio (TTM)—
Forward P/E36.92
P/S ratio15.79
P/B ratio204.69
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$71M
Free cash flow (TTM)-$4M
Total cash$305M
Total debt$220M
Debt / equity402.84
Current ratio1.39
Income Statement
Total revenue (TTM)$708M
Revenue per share (TTM)14.07
Gross profit (TTM)$656M
EBITDA (TTM)-$167M
Net income (TTM)-$188M
EPS diluted (TTM)-3.72
Shares outstanding51,459,766
Float shares43,546,283
Profitability
Gross margin92.60%
Operating margin-32.83%
EBITDA margin-23.61%
Net margin-26.59%
Efficiency
Return on assets (TTM)-16.84%
Return on equity (TTM)-349.38%
Price History
Current price$217.38
52 Week high$234.29
52 Week low$96.09
50 day average$176.73
200 day average$150.39
Average volume (10 day)1,236,000
1-year beta0.58
1-year price target$270.28
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:35 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com